Takeover Possibility
For Trump Media SPAC, the Charts Are Bearish and the Strategy Simple
Digital World Acquisition is having a rough go of it right now.
With Mergers Picking Up in the Beaten-Up Biotech Sector, Here's a Target I Like
This particular biotech company just saw its stock whacked but still holds a lot of promise.
Kohl's Fundamental Story and Charts Are Both Problematic
There's a key price level to watch.
Twitter and Musk, Monday Reversal, Treasuries, Energy's Hammer, Kohl's Cash-Out?
I found two very interesting takeaways from Monday's sharp market reversal.
With Musk's Stake in Twitter, Investing Becomes Tougher Than Trading the Shares
Could Elon's move signal an eventual full blown takeover bid?
What Recent Talk About Softbank and Alibaba Says About Both Firms
A chaotic news cycle has led to an equally wild swing in the share price of both names in the past week.
The Bedraggled Biotech Sector Finally Offers a Glimmer of Hope
Two recent acquisition deals and big drug companies that are flush with cash provide reason to believe biotech stocks could rebound in 2022
Kohl's Appears Worth Snatching Up From the 'Sale' Rack
The department store retailer seems undervalued based on activist investor interest and the inclusion of Sephora shops in many of its locations.
PayPal Still Looks Bullish if Support Continues to Hold
The shares of the payments technology company wavered a bit on news of its interest in Pinterest but its technical signs still are good.
Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up
A recent trio of acquisition deals indicates the doldrums in the sector may be over.